Generate:Biomedicines

The past year has seen an increase in investment in biopharma companies following a couple of lean years, but the sector is not fully out of the woods yet. However, most industry leaders see funding

Alliances centered on artificial intelligence and machine learning (AI/ML) applications have become ubiquitous in the biopharmaceutical sector in recent years and are projected to accelerate. But a re

Generative artificial intelligence firm Generate Biomedicines unveiled a novel protein discovery and development collaboration with Novartis AG on 24 September that it called part of an effort to

Drug makers have embraced artificial intelligence and machine learning (AI/ML) for discovering and developing new drugs, but it requires significant investment. A recent report from Accenture aims to